Bionano Genomics, Inc. Reiterated revenue guidance for the full year 2023. For the year, the company Reiterated revenue guidance of $35.0 minion to $38.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7861 USD | +3.57% | +4.81% | -58.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-58.41% | 48.13M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B | |
+26.76% | 32.03B |
- Stock Market
- Equities
- BNGO Stock
- News Bionano Genomics, Inc.
- Bionano Genomics, Inc. Reiterates Revenue Guidance for the Full Year 2023